🇺🇸 FDA
Patent

US 8664227

Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

granted A61PA61P43/00A61P9/04

Quick answer

US patent 8664227 (Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents) held by Theravance, Inc. expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P43/00, A61P9/04, A61P9/12